In a landmark move reinforcing Saudi Arabia’s position at the forefront of healthcare innovation, PGxAI a portfolio company of Najashi Holding, has signed a Memorandum of Understanding with Lean Business Services, a subsidiary of the Public Investment Fund, during the Global Health Exhibition 2025.
This strategic partnership marks a significant step toward advancing precision medicine and genomics through artificial intelligence, aligning with the Kingdom’s ambition to lead in next-generation healthcare technologies. The collaboration will focus on integrating advanced AI-driven solutions into clinical and research environments, enabling faster, more accurate, and highly personalized healthcare outcomes.
At the heart of this collaboration is PGxAI’s pioneering technology, developed in Silicon Valley and rooted in cutting-edge research. The company has built an advanced AI-powered multiomics platform capable of analyzing complex genomic data with unprecedented speed and accuracy. What traditionally required weeks of laboratory processing and analysis can now be achieved in a matter of minutes, dramatically accelerating the detection of genetic mutations and enabling early cancer diagnosis.
PGxAI’s suite of solutions spans pharmacogenomics, carrier screening, and early disease detection, offering healthcare providers powerful tools to tailor treatments to individual genetic profiles. By transforming vast amounts of biological data into actionable clinical insights, these innovations are redefining how precision medicine is practiced moving from reactive treatment to proactive, preventive care.
Through this partnership, Lean will play a critical role in enabling the integration and scalability of PGxAI’s technologies across the Kingdom’s healthcare infrastructure. Backed by PIF, Lean’s digital health capabilities and national reach will support the localization of these advanced solutions, ensuring they are effectively embedded within Saudi Arabia’s healthcare ecosystem.
This collaboration not only highlights Najashi Holding’s commitment to investing in transformative healthcare technologies but also underscores its role in driving localization and knowledge transfer within the Kingdom. By supporting PGxAI’s expansion and facilitating high-impact partnerships, Najashi is actively contributing to building a robust genomics sector in Saudi Arabia.
Aligned with the goals of Saudi Vision 2030, this partnership represents a powerful convergence of innovation, investment, and national strategy. It sets the stage for a new era of intelligent, data-driven healthcare—one that enhances patient outcomes, advances scientific discovery, and positions Saudi Arabia as a global leader in precision medicine.